87 related articles for article (PubMed ID: 9167045)
1. Clinical importance of interleukin-2 receptor alpha-chain expression in acute leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.
Nakase K; Kita K; Kageyama S; Tsuji K; Miyanishi E; Miwa H; Tanaka I; Shirakawa S; Tanaka I; Anazawa H; Tsutani H; Kyo T; Dohy H; Kamada N; Doi S; Nasu K; Uchino H
Cancer Detect Prev; 1997; 21(3):273-9. PubMed ID: 9167045
[TBL] [Abstract][Full Text] [Related]
2. Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia.
Moon Y; Kim Y; Kim M; Lim J; Kang CS; Kim WI; Shim SI; Chung NG; Park YH; Min WS; Han K
Ann Clin Lab Sci; 2004; 34(4):410-5. PubMed ID: 15648782
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells.
Nakase K; Kita K; Otsuji A; Anazawa H; Hoshino K; Sekine T; Shirakawa S; Tanaka I; Nasu K; Tsutani H
Br J Haematol; 1992 Mar; 80(3):317-26. PubMed ID: 1581211
[TBL] [Abstract][Full Text] [Related]
5. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
6. [Interleukin 2 (IL-2) and its receptor (IL-2R) in healthy individuals and with various disease states].
Mazur G; Frydecka I
Acta Haematol Pol; 1993; 24(4):307-13. PubMed ID: 8303976
[TBL] [Abstract][Full Text] [Related]
7. [The expression of IL-2 receptor subunits on various leukemic cells].
Ohashi Y; Kurahayashi Y; Ikeda S; Arima N; Sasaki T; Tamate E; Yokomichi H; Sugamura K
Nihon Rinsho; 1992 Oct; 50(10):2471-5. PubMed ID: 1447819
[TBL] [Abstract][Full Text] [Related]
8. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
9. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 receptor beta and CD57 expression in orbital tissues from patients with chronic, stable thyroid-associated ophthalmopathy.
Rosen CE; Rizzuto PR; Kennerdell JS; Burde RM; Wall JR
Alaska Med; 1994; 36(4):177-82, 207. PubMed ID: 7531401
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.
Muñoz L; Nomdedéu JF; López O; Carnicer MJ; Bellido M; Aventín A; Brunet S; Sierra J
Haematologica; 2001 Dec; 86(12):1261-9. PubMed ID: 11726317
[TBL] [Abstract][Full Text] [Related]
12. [In vitro induction of autologous T cell killing by heat treated human chronic myelogenous leukemia cells].
He X; You S; Bian S; Liao X; Li M; Ma S; Ge W; Qian L
Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):287-90. PubMed ID: 11876993
[TBL] [Abstract][Full Text] [Related]
13. Early immune response and regulation of IL-2 receptor subunits.
Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
[TBL] [Abstract][Full Text] [Related]
14. P53 protein expression in human leukemia and lymphoma cells.
Koníková E; Kusenda J
Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
[TBL] [Abstract][Full Text] [Related]
15. [Immunophenotype of blast crisis in chronic myeloid leukemia].
Favre G; Passweg J; Hoffmann T; Speck B; Gratwohl A; Tichelli A
Schweiz Med Wochenschr; 1998 Oct; 128(42):1624-6. PubMed ID: 9824896
[TBL] [Abstract][Full Text] [Related]
16. Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells.
Tsilivakos V; Tsapis A; Kakolyris S; Iliakis P; Perraki M; Georgoulias V
Leukemia; 1994 Sep; 8(9):1571-8. PubMed ID: 8090033
[TBL] [Abstract][Full Text] [Related]
17. Different types of human leukemias express the message for TNF-alpha and interleukin-10.
Schulz U; Munker R; Ertl B; Holler E; Kolb HJ
Eur J Med Res; 2001 Aug; 6(8):359-63. PubMed ID: 11549518
[TBL] [Abstract][Full Text] [Related]
18. [Study on cellular immunity in children with respiratory syncytial virus associated acute lower respiratory infection].
Chen Z; Dong Y; Zhang M; Li G
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):263-6. PubMed ID: 15617344
[TBL] [Abstract][Full Text] [Related]
19. Cytokine expression of T cells in chronic myeloid leukemia.
Liu Y; Kleine HD; Engel H; Andreeff M
Chin Med J (Engl); 2000 Mar; 113(3):232-5. PubMed ID: 11775253
[TBL] [Abstract][Full Text] [Related]
20. A novel role of metalloproteinase in cancer-mediated immunosuppression.
Sheu BC; Hsu SM; Ho HN; Lien HC; Huang SC; Lin RH
Cancer Res; 2001 Jan; 61(1):237-42. PubMed ID: 11196168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]